Abstract 1457: Decoding the molecular mechanisms related to mutations in the GNAQ/11 and BAP1 genes in ocular melanoma

GNAQ公司 BAP1型 黑色素瘤 基因 癌症研究 遗传学 突变 生物 医学
作者
Aurélie Fuentes-Rodriguez,Andrew Mitchell,Joël Rousseau,Jacques P. Tremblay,Solange Landreville
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 1457-1457
标识
DOI:10.1158/1538-7445.am2024-1457
摘要

Abstract Uveal melanoma (UM) is the most frequent intraocular cancer in adults and 50% of patients develop liver metastases for which no treatment is effective. According to The Cancer Genome Atlas, 92% of cases are characterized by early mutations in two genes coding for alpha subunits of G protein coupled receptors (GPCR): G protein subunit alpha q (GNAQ) or 11 (GNA11). These mutations are mostly found in the codon Q209 causing a constitutive activation of different signaling pathways linked to cellular proliferation such as MAPK and PKC. Furthermore, a bi-allelic inactivation of the BRCA1 associated protein-1 (BAP1) is found in 83% of metastatic UM and causes a loss of function of this protein. Our hypothesis is that the inactivation of compensatory pathways in the absence of these proteins and the understanding of pathways essential only to mutated cells will pave the way for the identification of better therapeutic candidates specific to UM cancer cells (UMCCs) to prevent metastatic progression and improve treatment options. The research objectives include the identification of compensatory signaling pathways in the absence of GNAQ/11 and BAP1 using classical CRISPR/Cas9, the discovery of essential molecular mechanisms for the survival of mutated UMCCs using Prime Editing, and the identification and characterization of novel therapeutic targets using 3D in vitro and in vivo models. First, the electroporation optimization using an eGFP plasmid demonstrated an efficiency of 40-50% for normal choroidal melanocytes (NCM) and 60-80% for UMCCs Mel285. Subsequent transfection with CRISPR complexes resulted in an average editing efficiency of approximately 20% for GNAQ/11 and 60% for BAP1. Currently, we have successfully established a GNAQ knockout (GNAQ-KO) Mel285 cell line. The characterization and validation of this cell line were performed through sequencing and Western blotting, confirming the creation of stop codons and the absence of GNAQ expression. We observed an overactivation of the ERK1/2 pathway and an upregulation of beta-catenin in the Mel285 GNAQ-KO line. Additionally, we noted a decrease in proliferation, adhesion, and migration on collagen I. For Prime editing, we constructed three plasmids with desired mutations. Preliminary tests in HEK293T cells showed an insertion efficiency of 4%, 20%, and 10% for GNAQ, GNA11, and BAP1, respectively, following a single treatment. Finally, in vitro testing has been started for inhibitors targeting compensatory pathways involving beta-catenin (WIKI4) and ERK1/2 (ASN007), in combination with the GNAQ/11 inhibitor (FR900359). These tests are being conducted on various mutant UMCCs for GNAQ/11.A better understanding of the altered pathways in our GNAQ/11 or BAP1 mutant isogenic cell lines will help to identify new drugs targeting specifically UM cells. Citation Format: Aurelie Fuentes-Rodriguez, Andrew Mitchell, Joël Rousseau, Jacques P. Tremblay, Solange Landreville. Decoding the molecular mechanisms related to mutations in the GNAQ/11 and BAP1 genes in ocular melanoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 1457.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
加菲丰丰应助徐木木采纳,获得10
2秒前
懵懂的土豆完成签到,获得积分10
4秒前
gypsi完成签到,获得积分10
4秒前
薰硝壤应助科研小风采纳,获得30
6秒前
111完成签到 ,获得积分10
7秒前
朱朱朱发布了新的文献求助10
8秒前
顾矜应助Nisaix采纳,获得10
10秒前
酷波er应助白敬亭采纳,获得10
12秒前
科研通AI2S应助柯孜采纳,获得10
15秒前
红柚发布了新的文献求助10
16秒前
lsy完成签到,获得积分20
18秒前
细心的小懒虫完成签到,获得积分10
20秒前
完美世界应助刘肉干采纳,获得10
20秒前
陶ni吉吉完成签到,获得积分10
22秒前
共享精神应助mingjingbingying采纳,获得10
24秒前
25秒前
薰硝壤应助傲娇的睫毛膏采纳,获得10
26秒前
26秒前
研友_VZG7GZ应助穆一手采纳,获得10
27秒前
欣慰碧琴完成签到,获得积分10
28秒前
善学以致用应助刚好采纳,获得10
28秒前
郜雨寒发布了新的文献求助10
29秒前
欧阳蛋蛋鸡完成签到 ,获得积分10
30秒前
WW完成签到,获得积分20
30秒前
30秒前
小晋发布了新的文献求助10
30秒前
32秒前
33秒前
Jian发布了新的文献求助10
35秒前
12345发布了新的文献求助10
35秒前
35秒前
35秒前
36秒前
37秒前
38秒前
39秒前
务实妖妖发布了新的文献求助10
41秒前
穆一手发布了新的文献求助10
41秒前
蓝毛衣完成签到 ,获得积分10
42秒前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3141296
求助须知:如何正确求助?哪些是违规求助? 2792352
关于积分的说明 7802183
捐赠科研通 2448490
什么是DOI,文献DOI怎么找? 1302608
科研通“疑难数据库(出版商)”最低求助积分说明 626650
版权声明 601237